EUR 1.7
(-5.56%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 9.76 Million EUR | 6.72% |
2022 | 9.14 Million EUR | 22.34% |
2021 | 7.47 Million EUR | 5.83% |
2020 | 7.06 Million EUR | 2.41% |
2019 | 6.89 Million EUR | 4.71% |
2018 | 6.58 Million EUR | -4.43% |
2017 | 6.89 Million EUR | 12.09% |
2016 | 6.15 Million EUR | 4.4% |
2015 | 5.89 Million EUR | -8.21% |
2014 | 6.41 Million EUR | 13.41% |
2013 | 5.65 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 2.25 Million EUR | -9.99% |
2024 Q2 | 2.25 Million EUR | 0.0% |
2023 Q1 | 2.37 Million EUR | -53.55% |
2023 Q4 | 2.5 Million EUR | -0.05% |
2023 FY | 10.11 Million EUR | 10.56% |
2023 Q2 | 4.91 Million EUR | 106.77% |
2023 Q3 | 2.5 Million EUR | -49.11% |
2022 Q1 | 2.15 Million EUR | -46.32% |
2022 FY | 9.14 Million EUR | 22.34% |
2022 Q4 | 5.12 Million EUR | 88.18% |
2022 Q3 | 2.72 Million EUR | -32.69% |
2022 Q2 | 4.04 Million EUR | 88.04% |
2021 Q2 | 3.47 Million EUR | 83.54% |
2021 Q4 | 4 Million EUR | 84.79% |
2021 Q1 | 1.89 Million EUR | -47.92% |
2021 Q3 | 2.16 Million EUR | -37.56% |
2021 FY | 7.47 Million EUR | 5.83% |
2020 Q2 | 3.44 Million EUR | 85.35% |
2020 FY | 7.06 Million EUR | 2.41% |
2020 Q1 | 1.85 Million EUR | -50.22% |
2020 Q3 | 1.91 Million EUR | -44.39% |
2020 Q4 | 3.63 Million EUR | 89.65% |
2019 Q2 | 3.16 Million EUR | 83.73% |
2019 Q4 | 3.73 Million EUR | 87.15% |
2019 FY | 6.89 Million EUR | 4.71% |
2019 Q1 | 1.72 Million EUR | 5.94% |
2019 Q3 | 1.99 Million EUR | -37.04% |
2018 FY | 6.58 Million EUR | -4.43% |
2018 Q4 | 1.62 Million EUR | 0.0% |
2018 Q3 | 1.62 Million EUR | -8.39% |
2018 Q2 | 1.77 Million EUR | 0.0% |
2018 Q1 | 1.77 Million EUR | -4.25% |
2017 Q1 | 1.66 Million EUR | 1.65% |
2017 Q2 | 1.66 Million EUR | 0.0% |
2017 FY | 6.89 Million EUR | 12.09% |
2017 Q4 | 1.85 Million EUR | 0.0% |
2017 Q3 | 1.85 Million EUR | 11.1% |
2016 Q1 | 1.5 Million EUR | -2.33% |
2016 Q3 | 1.64 Million EUR | 9.01% |
2016 Q4 | 1.64 Million EUR | 0.0% |
2016 FY | 6.15 Million EUR | 4.4% |
2016 Q2 | 1.5 Million EUR | 0.0% |
2015 Q1 | 1.54 Million EUR | -9.64% |
2015 Q4 | 1.54 Million EUR | 5.43% |
2015 Q3 | 1.46 Million EUR | 0.14% |
2015 Q2 | 1.46 Million EUR | -5.41% |
2015 FY | 5.89 Million EUR | -8.21% |
2014 Q2 | 1.54 Million EUR | -2.34% |
2014 Q3 | 1.56 Million EUR | 1.09% |
2014 Q4 | 1.7 Million EUR | 9.11% |
2014 FY | 6.41 Million EUR | 13.41% |
2014 Q1 | 1.58 Million EUR | -6.06% |
2013 Q3 | 1.43 Million EUR | 10.81% |
2013 Q2 | 1.29 Million EUR | 3.91% |
2013 Q4 | 1.68 Million EUR | 17.92% |
2013 FY | 5.65 Million EUR | 0.0% |
2013 Q1 | 1.24 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Evrofarma SA | 3.03 Million EUR | -221.909% |
Kri-Kri Milk Industry S.A. | 32.46 Million EUR | 69.94% |
Loulis Food Ingredients S.A. | 20.52 Million EUR | 52.451% |